Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients1-Reference-Cited by-同舟云学术

Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients1

Published:2003-08-27 Issue:4 Volume:76 Page:631-636
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Jordan S. C.,Vo A.,Bunnapradist S.,Toyoda M.,Peng A.,Puliyanda D.,Kamil E.,Tyan D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference28 articles.

1. Significance of the positive crossmatch test in kidney transplantation;Patel;N Engl J Med,1969

2. Effect of waiting time on renal transplant outcome;Meier-Kriesche;Kidney Int,2000

3. Improved graft survival after renal transplantation in the United States, 1988 to 1996 [see comments];Hariharan;N Engl J Med,2000

4. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin;Kazatchkine;N Engl J Med,2001

5. Intravenous gamma globulin (IVIG) inhibits lymphocytotoxic antibody in vitro;Jordan;J Am Soc Nephrol,1991

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of the sensitized pediatric renal transplant candidate;Pediatric Transplantation;2024-02-24

2. History of living donor kidney transplantation;Living Donor Organ Transplantation;2024

3. Desensitization in Solid Organ Transplantation;Biomedical Engineering;2023-11-23

4. Belatacept-Based Maintenance Immunosuppression Controls the Post-Transplant Humoral Immune Response in Highly Sensitized Nonhuman Primates;Kidney360;2022-12

5. Strategies to Overcome HLA Sensitization and Improve Access to Retransplantation after Kidney Graft Loss;Journal of Clinical Medicine;2022-09-28